학술논문
101 Laparoscopic splenectomies for the treatment of benign and malignant hematologic disorders
Document Type
Journal Article
Author
Source
Subject
*SPLENECTOMY
*BLOOD diseases
*PURPURA (Pathology)
*THERAPEUTICS
*COMPARATIVE studies
*LAPAROSCOPY
*RESEARCH methodology
*MEDICAL cooperation
*RESEARCH
*SPLEEN diseases
*THROMBOPENIC purpura
*EVALUATION research
*CASE-control method
*HEMATOLOGIC malignancies
*
*
*
*
*
*
*
*
*
*
*
*
*
Language
ISSN
0002-9610
Abstract
: BackgroundLaparoscopic splenectomy (LS) is the surgical approach of choice for patients with hematologic disorders requiring splenectomy. Patients with idiopathic thrombocytopenic purpura (ITP) have normal to slightly enlarged spleens and benefit the most from LS.: MethodsWe reviewed the perioperative outcomes in 101 patients who underwent LS between May 1996 and December 2002. Patients were divided into three groups—ITP, other benign, and malignant hematologic disorders—and compared.: ResultsThe ITP patients (n = 48) had significantly smaller spleens and operative times compared with the other groups. Splenomegaly in the other benign (n = 23) and malignant hematologic disorders (n = 30) groups was responsible for higher open conversion rates and greater need for hand-assisted laparoscopic splenectomy (HALS).: ConclusionsLaparoscopic splenectomy and HALS can be performed with good results for benign and malignant hematologic disorders. The benefits of HALS are similar to LS, so there should be a low threshold for HALS in patients with large spleens. [Copyright &y& Elsevier]